Gene Therapy : Impact Factor & More
eISSN: 1476-5462pISSN: 0969-7128
Share this on:
Key Metrics
CiteScore 
7.6
H-Index
169
Impact Factor
5 - 10
SJR
Q1Genetics
SNIP
0.82
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Gene Therapy
Gene Therapy Journal Specifications
| Overview | |
| Publisher | SPRINGERNATURE |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1994 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Gene Therapy
An engineered helper plasmid generates differential E4orf6 and L4-22/33K gene expression increasing AAV vector production.
- 7 Aug 2026
- Gene therapy
Precision correction of the GJB2 c.235delC mutation by prime editing in vitro.
- 6 Aug 2026
- Gene therapy
A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease.
- 6 Aug 2026
- Gene therapy
Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice.
- 29 Jul 2026
- Gene therapy
SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.
- 29 Jul 2026
- Gene therapy
RAAV production cost analysis: Indication-specific cost per dose and reduction strategies.
- 21 Jul 2026
- Gene therapy
An engineered helper plasmid generates differential E4orf6 and L4-22/33K gene expression increasing AAV vector production.
- 7 Aug 2026
- Gene therapy
Precision correction of the GJB2 c.235delC mutation by prime editing in vitro.
- 6 Aug 2026
- Gene therapy
A gene therapy approach to prevent dilated intercellular space, a hallmark of gastroesophageal reflux disease.
- 6 Aug 2026
- Gene therapy
Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice.
- 29 Jul 2026
- Gene therapy
SACF and GILA for in vitro transformation assessment of CRISPR/Cas9-edited cell therapy candidates: a multi-site study.
- 29 Jul 2026
- Gene therapy
RAAV production cost analysis: Indication-specific cost per dose and reduction strategies.
- 21 Jul 2026
- Gene therapy
FAQs on Gene Therapy
How long has Gene Therapy been actively publishing? 
What is the publishing frequency of Gene Therapy?
How many articles did Gene Therapy publish last year?
What is the eISSN & pISSN for Gene Therapy?
What is Citescore for Gene Therapy?
What is the H Index for Gene Therapy ?
What is SNIP score for Gene Therapy?
What is the SJR for Gene Therapy?
Who is the publisher of Gene Therapy?
